Ellis, Cara
Ramzy, Adam
Kieffer, Timothy J.
Article History
First Online: 16 August 2017
Competing interests
: T.J.K. has patents related to the material covered in this Review and is a co-founder and shareholder of enGene, a biotechnology company developing gene therapy approaches for metabolic diseases, including diabetes. He has also collaborated with scientists at BetaLogics and ViaCyte on stem-cell-based therapies for diabetes and received funding from Janssen R&D for this research.